Use of anajana in pterygium (Arma)

An open label double arm controlled clinical study of Shankanjana in Arma( Pterygium) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090941

Enrollment

Registered

2025-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H110- Pterygium of eye

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged between 30 to 60 years of either gender will be selected. 2. Patients having the classical Lakshanas of Arma will be selected. 3. Encroaching of Pterygium limited to corneal margins. 4. Pterygium with both unilateral and bilateral will be considered.

Exclusion criteria

Exclusion criteria: 1.Patients with Autoimmune diseases that has caused Pterygium. 2.Pterygium with any other ocular pathologies. 3.Pseudopterygium and Pinguecula. 4.Patients with Chedhana yogya Arma as explained in classical text will be excluded.

Design outcomes

Primary

Measure	Time frame
PRIMARY OUTCOME MEASURE 1.Improvement in the Subjective parameters 2. Decrease in Length and Width of the Arma. SECONDARY OUTCOME MEASURES: 1.Sustained effect of treatment on Subjective Parameters 2.To develop easily approachable cost-effective treatment. Timepoint: 45 days	—

Secondary

Measure	Time frame
SECONDARY OUTCOME MEASURES: 1. Sustained effect of treatment on Subjective Parameters 2. To develop easily approachable cost-effective treatment. Timepoint: 45 DAYS	—

Countries

India

Contacts

Public ContactDr Sharan prasad Kolliyavar

SDM INNSTITUTE OF AYURVEDA COLLEGE AND HOSPITAL

drsharanprasad.k@gmail.com9844897784

Outcome results